About
Careers
Sign In
eMed Empathetic AI™ Population Health Platform lets the miracle
of GLP-1s/GIPs be enjoyed by your population
Corporations
Government
Unions
NGOs
Complete the survey to have eMed analyze the benefits of our pop health program for your population
Survey
Empathetic AI™ Population Health Platform lets the miracle of GLP-1s/GIPs be enjoyed by your population
24/7/365 Proctoring
● At-home through mobile
● AI Biometric capture tools
● On label drug prescribing
● At home supervised blood collection
Adherence and accountability
● Weekly check-ins
● Quarterly prescribing/dosage management
● Bi-annual blood screenings
● 24/7 side effect support
Empathetic AI™ Predictive Analytics
● Daily and cumulative ROI analysis
● $200M+ tech build with 145 patent filings
● HIPAA, SOC2, HL7 transport
● Interactions auditable/archived for 10 years
Infinite Scale
● 6+ million customers
● 1200+ corporations and governments
● 100K+ proctors
Instant access to live care.
No appointments ever
Complete the survey to have eMed analyze the benefits of our pop health program for your population
Type of organization
Select one...
Corporation
NGO
Union
Govenment
Other
Organization name
Number of Covered Lives
Select one...
Less than 2,000
2,000–5,000
5,000–20,000
20,000+
Do you currently cover GLP-1s/GIPs for conditions beyond Type II Diabetes?
Select one...
Yes
No
Not Sure
Who is your benefits consultant or broker?
Select one...
Aon
Brown & Brown
Chubb
Gallagher
HUB
Lockton
Marsh & McLennan
Mercer
Segal
USI Insurance Services
Willis Towers Watson
Other
First & last name
Phone
Email address
Title
By submitting this form, you consent to our
Terms and Conditions.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form, please try again